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these cases are attributable to the male partner 1）. The 
origin of male-factor infertility remains largely unex-
plained. Genetic factors cause approximately 10-15％ 
of the male infertility 2）. Male fertility depends on suc-
cessful spermatogenesis, in which a number of genes 
participates. Thus, it is evident that deletions or muta-
tions in genes controlling spermatogenesis would 
result in infertility 3）.
Cytogenetic studies in infertile men have revealed a 
gene that controls spermatogenesis；this azoospermia 
factor （AZF） is located on the long arm of the Y 
chromosome （Yq11）4）. Three spermatogenic loci in 
Yq11 have been classified into three regions, AZFa, 
INTRODUCTION
Infertility is a major reproductive health problem in 
Japan relating to the trend towards later marriage. 
Worldwide reports suggest that infertility affects 15％
-20％ of couples of reproductive age. Nearly 50％ of 
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SUMMARY
Genetic factors are responsible for approximately 15％ of male infertility. The azoospermia factors AZFa, 
AZFb （P5/proximal P1）, and AZFc （b2/b4） present on Yq are most important for spermatogenesis. Here, 
we evaluated frequencies of microdeletions of AZFa, AZFb, AZFc in azoospermia due to spermatogenic 
dysfunction in the Japanese population. The overall prevalence of Y chromosome microdeletions in infertile 
men was 8.1％ （79/980）. The prevalence of Y chromosome microdeletions in AZFa, AZFb, AZFabc, 
AZFbc （P5/distal P1 or P4/distal P1） and AZFc was 0.1％ , 0.8％ , 0.7％ , 2.0％ and 4.4％ , respectively. 
Microdissection for testicular sperm extraction failed in all patients with microdeletion in AZFa, AZFb, 
AZFabc, and AZFbc, although sperm could be retrieved in 28/43 patients with AZFc deletions （62.2％）. 
The presence of an AZFc deletion was associated with significantly better sperm retrieval than the 33.0％ 
retrieval rate in idiopathic non-deleted azoospermic men undergoing microdissection for testicular sperm 
extraction at our institution during the study period. We conclude that Y chromosome microdeletion test-
ing is essential for genetic and preoperative counseling in these patients.
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AZFb and AZFc5）. Each AZF region contains several 
genes that play a role in different stages of spermato-
genesis. It is likely that further analysis of these indi-
vidual genes in infertile males will result in more pre-
cise genotype-phenotype correlations. Interstitial or 
terminal deletions of all AZFa are rare and usually 
produce the severe phenotype of Sertoli-cell-only 
（SCO） syndrome6）. Interstitial or terminal deletions of 
AZFb （P5/proximal P1） and AZFbc （P5/distal P1 or 
P4/distal P1） are uncommon and usually result in 
severe azoospermia 7）. Interstitial or terminal deletions 
of AZFc （b2/b4） only are relatively common and 
result in a variable infertility phenotype, ranging from 
azoospermia and SCO to severe or mild oligozoosper-
mia 8）. The frequency of Y chromosome microdeletions 
in males with azoospermia or severe oligozoospermia 
is about 5％ -15％6）.
In the present study we report our experience in 
the diagnosis and surgical management of azoosper-
mia due to spermatogenic dysfunction in patients with 
Y chromosome microdeletions. Our series of microdis-
section-testicular sperm extractions （micro-TESE） in 
men with Y chromosome microdeletions is the largest 
in Japan.
MATERIALS and METHODS
Criteria for including patients
For the present study, we recruited 980 men with 
azoospermia due to spermatogenic dysfunction （ASD）, 
aged 20-51 years. These subjects were ASD patients 
visiting the Dokkyo Medical University Koshigaya 
Hospital and affiliated institutions. All had primary 
infertility for more than a year. After a 2-7 day peri-
od of sexual abstinence, a semen sample was obtained 
from each patient. Complete semen analyses were 
repeated at least twice before a diagnosis of azoosper-
mia was made. To determine the presence of sperm, 
the ejaculate was centrifuged and thoroughly exam-
ined visually.
Informed consent forms were obtained from each 
infertile man before inclusion in the study. The Insti-
tutional Review Board of the Dokkyo Medical Univer-
sity Koshigaya Hospital approved this study.
Lymphocyte chromosome spreads were prepared 
using routine methods and karyotypes were analyzed 
by G-banding. For each individual, a minimum of 30 
metaphase spreads was analyzed. Patients with micro-
deletions associated with abnormal karyotypes （e.g. 
46,XX male, 47,XXY and balanced rearrangements 
such as reciprocal translocations or inversions）, and/
or obstructive azoospermia were excluded from the 
present study.
PCR for sequence-tagged sites
Y chromosome microdeletion screening was per-
formed by multiplex polymerase chain reaction （PCR） 
of DNA extracted from peripheral blood leukocytes. 
For each patient, genomic DNA was extracted from 
peripheral blood by the QIAamp DNA mini extraction 
kit （Qiagen, Venlo, The Netherlands）. The Y Chromo-
some Deletion Detection System, Version 2.0 （Prome-
ga, Madison, WI） was used for to identify Y chromo-
some deletions. Nineteen sequence-tagged sites （STS） 
within the AZF region of Yq11 （SY81, SY86, SY84, 
SY182, SY121, SYPR3, SY124, SY127, SY128, SY130, 
SY134, SY145, SY152, SY242, SY208, SY254, SY255 
and SY157） and the sex-determining region of the Y 
（SRY） gene, sY14, were targeted for PCR amplifica-
tion. DNA from a fertile man served as a positive con-
trol and DNA from women was used as the negative 
control. To confirm multiplex PCR results that indicat-
ed a Y chromosome microdeletion, single primer PCR 
analyses were performed in duplicate for all deleted 
STSs and two flanking STSs. When Y chromosome 
microdeletion was found, patients were screened 
twice with multiplex PCR using a different blood sam-
ple. Given the lack of convincing data regarding the 
clinical relevance of partial deletions of the AZFc 
region, patients with such partial AZFc deletions were 
considered non-deleted in this analysis.
Micro-TESE
A single surgeon performed micro-TESE for all 
enrolled ASD patients. The outcomes in patients with 
Y chromosome microdeletions were compared with 
outcomes in patients without Y chromosome microde-
letions. The significance of differences between sperm 
retrieval rates by micro-TESE in patients with or 
without Y chromosome microdeletions was estimated 
using Fisher’s exact test.
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RESULTS
Of 980 ASD patients tested, we identified 79 with Y 
chromosome microdeletions （8.1％）. The specific 
microdeletion status, and the number of men found to 
have each deletion are depicted in Table 1.
Outcomes of micro-TESE in these patients are pre-
sented in Table 2. All patients who were enrolled in 
this study underwent micro-TESE, including 901 
ASD patients without Y chromosome microdeletions. 
Micro-TESE universally failed in men with AZFa, 
AZFb, AZFbc, and AZFabc deletions, but was suc-
cessful in 28 of 43 patients with complete AZFc dele-
tions （62.2％）. Micro-TESE was more often successful 
in AZFc-deleted patients than ASD patients without 
Y chromosome microdeletions, for whom the surgical 
sperm retrieval rate was ＝33.0％ （P＜0.05）. Both 
maturation arrest and SCO were present as patholo-
gies in testicular specimens from patients with AZFb 
or AZFc deletions. On the other hand, in patients with 
AZFa, AZFabc and AZFbc deletions, the pathology 
observed was solely SCO, not maturation arrest. 
G-banding revealed that all patients with AZFabc 
deletion had 46, XYq- or 46, Xmar＋.
DISCUSSION
In the present study we assessed the prevalence of 
Y chromosome microdeletions in Japanese ASD 
patients. To the best of our knowledge, the tested 
population reported in this study represents the larg-
est cohort of ASD patients that has been tested for Y 
chromosome microdeletions in Japan. Amongst 980 
ASD patients, we identified 79 men （8.1％） with 
microdeletions in the Y chromosome spanning the 
AZFa, AZFb and AZFc loci. The frequency of Y chro-
mosome microdeletions in infertile men from Japan 
was thus similar to the frequency reported in other 
countries and regions 9）.
Table 1　 Prevalence of different Y microdeletions in patients with 
azoospermia due to dysfunctional spermatogenesis
Number of patients ％
Total screened 980
AZFa   1 0.1
AZFb   8 0.8
AZFa＋b＋c   7 0.7
AZFb＋c  20 2.0
AZFc  43 4.4
Any Y microdeletion  79 8.1
Table 2　Outcomes of micro-TESE in azoospermic men stratified by Y microdeletion status.
Etiology of 
azoospermia
Sperm 
retrieved
Sperm not 
retrieved
Sperm retrieval 
rate （％） Pathology
AZFa   0   1   0 SCO：1
AZFb   0   8   0 MA：3；SCO：5
AZFa＋b＋c   0   7   0 SCO：7
AZFb＋c   0  20   0 SCO：20
AZFc   28  15 62.2＊ MA：5；SCO：10＊＊
Nondeletion  297 604 33.0＊
Note：TESE, testicular sperm extraction；AZF, azoospermic factor；MA, maturation arrest；
SCO, Sertoli cell-only syndrome
 ＊  Sperm retrieval rate in men with AZFc deletions was significantly higher than in non-
deleted ADS patients （P＜0.05, Fisher’s exact test）.
＊＊  Diagnosis of patients with AZFc deletions from whom sperm could be retrieved was solely 
SCO
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Thirty-six patients （3.6％） had microdeletions 
including AZFa and/or AZFb in this study. We report 
only micro-TESE results, because we have not seen 
any men with deletions of the AZFa or AZFb regions 
that nonetheless had sperm on micro-TESE. Clinically, 
on counselling we now recommend primary use of 
donor sperm rather than TESE for men with dele-
tions that involve complete loss of the AZFa or AZFb 
regions. For these unfortunate patients, Y chromo-
some microdeletion testing avoids undergoing unnec-
essary surgery and emphasizes the need for donor 
sperm or adoption.
We found AZFc microdeletions in 43 （4.4％） of the 
ASD patients tested. Many studies have reported that 
mature spermatozoa are present in about half of 
patients with AZFc deletions. Our data demonstrated 
that these patients had a significantly better microsur-
gical sperm retrieval rate （62.2％） relative to men 
with idiopathic ASD but without deletions （33.0％）. 
The non-deleted ASD cohort excluded patients with 
identifiable conditions that have a higher rate of 
sperm retrieval with micro-TESE, including Klinefel-
ter’s syndrome 10）. Deletions in the AZFc region are 
invariably more frequently observed than deletions in 
the AZFa and AZFb loci in all published studies 11）. 
Azoospermic men have a higher incidence of microde-
letions than oligozoospermic men and consequently 
the frequency of deletions reported from different lab-
oratories may vary from 2 to 10％ （or even higher） 
reflecting the composition of the study population 9）.
In our experience, this information has been useful 
for preoperative counseling of couples who are consid-
ering micro-TESE. Y chromosome microdeletions are 
becoming common in Japan, justifying routine testing 
in couples considering assisted fertility interven-
tions 12）.
Among the available studies of STS in different loci, 
including those of the European Andrology Associa-
tion （EAA）, recommended markers had been used 
for detection of Y chromosome microdeletion in infer-
tile men 9）. In azoospermic men, Y chromosome micro-
deletion testing not only provides essential information 
for genetic counseling, but it helps patients and their 
physicians make more informed decisions about surgi-
cal sperm retrieval.
On correlating the deletion pattern with testicular 
histology, the deletion of AZFa was found to be asso-
ciated with complete absence of germ cells and the 
presence of Sertoli cells in the seminiferous tubules. 
The deletion of AZFb was associated with develop-
mental arrest of germ cells at the pachytene stage. 
The deletion of AZFc was variably associated with 
SCO syndrome, developmental arrest of germ cells at 
the spermatid stage and maturation arrest. The genes 
at each locus act at a particular stage of germ cell dif-
ferentiation, and deletion of a particular AZF locus 
results in a characteristic phenotype 13）. Results from 
our study of testicular biopsies are consistent with 
reports in the literature. Identification of gene prod-
ucts and their biological actions is necessary to under-
stand the influence of AZF gene deletions on forma-
tion of mature spermatozoa. Further, copy-number 
variations in Y chromosomal AZF regions have been 
associated with the risk of spermatogenic failure 14）. 
Some studies have shown that the genetic basis of 
infertility should be addressed after a detailed consid-
eration of different genetic factors, such as X chromo-
some mutations 15） and mitochondrial DNA muta-
tions 16）. Recently, a genome-wide association study 
revealed that 41 single-nucleotide polymorphisms 
（SNPs） were significantly correlated with family size 
or birth rate 17）. In any case, further genome analysis 
for infertile patients should be considered as very 
important in the future.
CONCLUSIONS
The present report details one of the largest studies 
of ASD caused by Y chromosome microdeletions in 
Japan or elsewhere. As such, it is a significant contri-
bution to the study of male infertility. Data presented 
here revealed a close relationship between microdele-
tions and spermatogenesis. Therefore, screening for 
microdeletions and chromosomal abnormalities should 
be performed and genetic counseling should be pro-
vided before micro-TESE in undertaken.
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